Holmberg D, Mattsson F, Xie S, Ness-Jensen E, et al. Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy. J Gastroenterol 2022 Oct 18. pii: 10.1007/s00535-022-01930.
PMID: 36258093